Open Access. Powered by Scholars. Published by Universities.®
Psychiatric and Mental Health Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- Adolescent (1)
- Baclofen (1)
- Buprenorphine (1)
- COVID-19 (1)
- Child (1)
-
- Inpatient detoxification (1)
- Mental health (1)
- Opioid withdrawal (1)
- Opioid-related disorders (1)
- Opioid-related disorders/therapy (1)
- Pandemics (1)
- Pediatrics (1)
- Psychological adaptation (1)
- Psychological distress (1)
- Psychological resilience (1)
- Substance abuse treatment centers (1)
- Substance withdrawal syndrome (1)
Articles 1 - 2 of 2
Full-Text Articles in Psychiatric and Mental Health
The Impact Of The Covid-19 Pandemic On The Physical And Mental Health Of School-Aged Children, Syed Azlan Abbas, Sufia Athar, Nadeem Zafar Jilani
The Impact Of The Covid-19 Pandemic On The Physical And Mental Health Of School-Aged Children, Syed Azlan Abbas, Sufia Athar, Nadeem Zafar Jilani
HCA Healthcare Journal of Medicine
The SARS-CoV-2 (COVID-19) pandemic caused a deleterious impact on global health. School-aged children were significantly impacted by the pandemic. These impacts may be attributed to the fact that this age group is at a vulnerable developmental stage and is susceptible to profound effects. We conducted a thorough literature review using PubMed, Medline, and Science Direct electronic database searches between 2020-2022. We retrieved 757 studies, 25 of which were included in our review. We considered the impact of the COVID-19 pandemic on the physical and mental health of school-aged children (5-18 years), and the results were analyzed and included in our …
A Retrospective Comparison Of The Effectiveness Of Buprenorphine Versus Baclofen For Acute Opioid Withdrawal, Matthew Hermenau, Benton Stamper, Kitty Leung, Raymond Pomm, Christina Guerrier, Joseph Cammilleri, Brittany Johnson
A Retrospective Comparison Of The Effectiveness Of Buprenorphine Versus Baclofen For Acute Opioid Withdrawal, Matthew Hermenau, Benton Stamper, Kitty Leung, Raymond Pomm, Christina Guerrier, Joseph Cammilleri, Brittany Johnson
HCA Healthcare Journal of Medicine
Background
A significant impediment to opioid cessation or dose reduction is mitigating withdrawal severity that has been shown to affect the course of opioid dependence. Current guidelines recommend the use of buprenorphine and methadone over alpha-2 adrenergic agonists. Baclofen, a GABA-B agonist, has promising results as an adjunct agent for opioid withdrawal but has not been compared to buprenorphine. This study compared the ability of buprenorphine and baclofen to mitigate acute opioid withdrawal.
Methods
This was a single-center, retrospective chart review of 63 patients with diagnosed opioid use disorder that received scheduled buprenorphine or baclofen for 3 days, in addition …